 |
|
Cefotaxime TherapyEvaluation of Its Effect on Bacterial Meningitis, CSF Drug Levels, and Bactericidal Activity
Dennis T. Mullaney, MD;
Joseph F. John, MD
Arch Intern Med. 1983;143(9):1705-1708.
Abstract
• Cefotaxime sodium was evaluated in the treatment of ten patients with bacterial meningitis. Seven of the patients were infected with unusual and difficult to eradicate pathogens. Eight of the ten patients had a favorable clinical response and rapid sterilization of their CSF. Trough CSF levels of cefotaxime (range, 5.6 to 44.3 µg/mL) and desacetylcefotaxime (3.7 to 44.0 µg/mL) were manyfold greater than the minimal bactericidal concentrations of the causative pathogens with the exception of the one Pseudomonas aeruginosa isolate. Trough CSF bactericidal titers ranged from 1:16 to 1:4,096 or more (median, 1:256) in the nine patients with susceptible pathogens. Trough cefotaxime and desacetylcefotaxime levels and bactericidal titers were maintained or actually increased over the course of therapy. Cefotaxime appears to be a promising new agent for the treatment of bacterial meningitis.
(Arch Intern Med 1983;143:1705-1708)
Author Affiliations
From the Infectious Diseases-Immunology Division, Department of Medicine, Medical University of South Carolina, and the Charleston Veterans Administration Medical Center.
Footnotes
Accepted for publication March 25, 1983.
Reprint requests to 916 Clinical Science Bldg, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425 (Dr Mullaney).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Ventriculitis in Newborns With Myelomeningocele
Charney et al.
Arch Pediatr Adolesc Med 1991;145:287-290.
ABSTRACT
|
